| P50 | author | Nicola Principi | Q63133894 |
| | Alessandro Porta | Q79624205 |
| | Susanna Esposito | Q24239756 |
| P2093 | author name string | Esse Menson | |
| | Mike Sharland | |
| | Maria Tsolia | |
| | Nikos Spyridis | |
| P2860 | cites work | The battle against emerging antibiotic resistance: should fluoroquinolones be used to treat children? | Q40636919 |
| | Chloramphenicol toxicity. | Q40838693 |
| | Use of meropenem in the treatment of serious infections in children: review of the current literature | Q41451178 |
| | Meropenem compared with ceftazidime in the empiric treatment of acute severe infections in hospitalized children. Italian Pediatric Meropenem Study Group | Q42678277 |
| | Pharmacokinetics and pharmacodynamics of linezolid in children with cystic fibrosis | Q44421400 |
| | Bacteriologic and clinical efficacy of high dose amoxicillin for therapy of acute otitis media in children | Q44469180 |
| | Antibiotic usage, dosage and course length in children between 0 and 4 years. | Q46035184 |
| | Pharmacokinetics and tolerance of linezolid for meticillin-resistant Staphylococcus aureus mediastinitis in paediatric patients | Q46189591 |
| | European survey on ethical and legal framework of clinical trials in paediatrics: results and perspectives. | Q53113527 |
| | Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. | Q54105670 |
| | Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study | Q57413315 |
| | A survey of the use of off-label and unlicensed drugs in a Dutch children's hospital | Q77123451 |
| | Use of antimicrobial agents for community-acquired lower respiratory tract infections in hospitalised children | Q77195547 |
| | Pharmacological differences between once daily and twice daily gentamicin dosage in newborns with suspected sepsis | Q79783132 |
| | Italian paediatricians and off-label prescriptions: loyal to regulatory or guideline standards? | Q81271449 |
| | Pediatric drug surveillance and the Food and Drug Administration's adverse event reporting system: an overview of reports, 2003-2007 | Q82607530 |
| | Registration of trials in children: update of current international initiatives | Q83871107 |
| | One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates | Q24244642 |
| | Drug toxicity in the neonate | Q28271740 |
| | Drug trials in children: problems and the way forward | Q33836061 |
| | Unlicensed and off-label drug use in children: implications for safety | Q34512876 |
| | Emerging role of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric respiratory-tract infections | Q34548131 |
| | Unlicensed and off label drug use in neonates | Q35287900 |
| | Surveillance for fatal suspected adverse drug reactions in the UK | Q35556183 |
| | Adverse drug reactions and off-label drug use in paediatric outpatients | Q35804191 |
| | Fluoroquinolone antibiotics in infants and children | Q36231221 |
| | Medicines for children licensed by the European Medicines Agency (EMEA): the balance after 10 years | Q36615046 |
| | The awareness among paediatricians of off-label prescribing in children: a survey of Italian hospitals. | Q36662507 |
| | Use of linezolid in children: an overview of recent advances | Q36688930 |
| | How do we ensure safe prescribing for children? | Q37061684 |
| | Antimicrobial policies in the neonatal units of the United Kingdom and Republic of Ireland | Q37073213 |
| | Unlicensed and off label drug use in paediatric wards: prospective study | Q37150383 |
| | Determinants of the drug utilization profile in the paediatric population in Italy's Lombardy Region | Q37201703 |
| | Off-label use of medicines in children: can available evidence avoid useless paediatric trials? The case of proton pump inhibitors for the treatment of gastroesophageal reflux disease. | Q37271717 |
| | Defining off-label and unlicensed use of medicines for children: results of a Delphi survey | Q37292801 |
| | Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children | Q37300756 |
| | Perinatal sepsis | Q37390300 |
| | Off-label, off-limits? Parental awareness and attitudes towards off-label use in paediatrics | Q37411159 |
| | Prescribing in paediatrics | Q37420202 |
| | Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections | Q37874412 |
| | Off label prescribing to children in primary care in Germany: retrospective cohort study | Q39600355 |
| | Unlicensed and off label drug use by children in the community: cross sectional study | Q39600363 |
| P433 | issue | 9 | |
| P304 | page(s) | 919-927 | |
| P577 | publication date | 2010-06-08 | |
| P1433 | published in | European Journal of Clinical Pharmacology | Q1376707 |
| P1476 | title | Off-label antibiotic use in children in three European countries | |
| P478 | volume | 66 | |